Melmed S (2020) Pituitary-tumor endocrinopathies. N Engl J Med 382(10):937–950
Article CAS PubMed Google Scholar
Melmed S, Kaiser UB, Lopes MB, Bertherat J, Syro LV, Raverot G, Reincke M, Johannsson G, Beckers A, Fleseriu M, Giustina A, Wass JAH, Ho KKY (2022) Clinical biology of the pituitary adenoma. Endocr Rev 43(6):1003–1037
Article PubMed PubMed Central Google Scholar
Raverot G, Burman P, McCormack A, Heaney A, Petersenn S, Popovic V, Trouillas J, Dekkers OM (2018) European society of endocrinology clinical practice guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol 178(1):G1–G24
Article CAS PubMed Google Scholar
Dekkers OM, Karavitaki N, Pereira AM (2020) The epidemiology of aggressive pituitary tumors (and its challenges). Rev Endocr Metab Disord 21(2):209–212
Article PubMed PubMed Central Google Scholar
Trouillas J, Roy P, Sturm N, Dantony E, Cortet-Rudelli C, Viennet G, Bonneville J-F, Assaker R, Auger C, Brue T, Cornelius A, Dufour H, Jouanneau E, François P, Galland F, Mougel F, Chapuis F, Villeneuve L, Maurage C-A, Figarella-Branger D, Raverot G (2013) A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol 126(1):123–135
DeLellis RA, Lloyd RV, Heitz PU (2004) World Health Organization classification of tumours: pathology and genetics of tumours of endocrine organs. IARC Press, Lyon, pp 9–74
Veleno M, Giampietro A, Raia S, Menotti S, Tartaglione T, Gaudino S, Doglietto F, De Marinis L, Pontecorvi A, Chiloiro S, Bianchi A (2024) Clinical implications of the 2022 WHO classification on the multidisciplinary management of PitNETS patients. Minerva Endocrinol 49(3). https://doi.org/10.23736/S2724-6507.24.04126-5
Mete O, Osamura RY, Asa SL (2022) Pituitary gland: introduction. WHO classification of tumours of endocrine organs [M]. 5th ed. Lyon: IARC Press
Ho KKY, Kaiser UB, Chanson P, Gadelha M, Wass J, Nieman L, Little A, Aghi MK, Raetzman L, Post K, Raverot G, Borowsky AD, Erickson D, Castaño JP, Laws ER, Zatelli MC, Sisco J, Esserman L, Yuen KCJ, Reincke M, Melmed S (2023) Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification. Nat Rev Endocrinol 19(11):671–678
Araujo-Castro M, Menéndez Torre E, Aida C-L, García-Centeno R, González L, Idrobo C, Achote E, Irigaray Echarri A, Rodríguez-Argulló MDM, Paja M, Guerrero-Pérez F, Castaño JP, Dolores Ollero García M, Novo-Rodríguez C, Tenorio-Jimenéz C, Villar-Taibo R, Bernabeu I, Díaz-López E, Calatayud M, Alvarez-Escola C, Martín-Rojas P, Recio-Córdova JM, Aulinas A, Asla Roca Q, Aviles MD, López Mezquita E, Fernández Argüeso M, González Molero I, Ruz-Caracuel I, Aldecoa I, García J, Martínez-Sáez E, Hanzu F, Marazuela M, Puig-Domingo M, Biagetti B (2025) Validation and limitations of the PANOMEN-3 predictive model for tumor recurrence and progression in pituitary tumors. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgaf252
Ho KKY, Fleseriu M, Wass J, Katznelson L, Raverot G, Little AS, Castaño JP, Reincke M, Lopes MB, Kaiser UB, Chanson P, Gadelha M, Melmed S (2024) A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis. Lancet Diabetes Endocrinol 12(3):209–214
Article PubMed PubMed Central Google Scholar
Ho KKY, Melmed S (2025) Pituitary adenomas: biology, nomenclature and clinical classification. Rev Endocr Metab Disord 26(2):137–146
Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BMK, Bronstein M, Chanson P, Fukuoka H, Gadelha M, Greenman Y, Gurnell M, Ho KKY, Honegger J, Ioachimescu AG, Kaiser UB, Karavitaki N, Katznelson L, Lodish M, Maiter D, Marcus HJ, McCormack A, Molitch M, Muir CA, Neggers S, Pereira AM, Pivonello R, Post K, Raverot G, Salvatori R, Samson SL, Shimon I, Spencer-Segal J, Vila G, Wass J, Melmed S (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: a pituitary society international consensus statement. Nat Rev Endocrinol 19(12):722–740
Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR, Boguszewski CL, Bronstein MD, Buchfelder M, Carmichael JD, Casanueva FF, Castinetti F, Chanson P, Findling J, Gadelha M, Geer EB, Giustina A, Grossman A, Gurnell M, Ho K, Ioachimescu AG, Kaiser UB, Karavitaki N, Katznelson L, Kelly DF, Lacroix A, McCormack A, Melmed S, Molitch M, Mortini P, Newell-Price J, Nieman L, Pereira AM, Petersenn S, Pivonello R, Raff H, Reincke M, Salvatori R, Scaroni C, Shimon I, Stratakis CA, Swearingen B, Tabarin A, Takahashi Y, Theodoropoulou M, Tsagarakis S, Valassi E, Varlamov EV, Vila G, Wass J, Webb SM, Zatelli MC, Biller BMK (2021) Consensus on diagnosis and management of Cushing’s disease: a guideline update. Lancet Diabetes Endocrinol 9(12):847–875
Article PubMed PubMed Central Google Scholar
Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C, van der Lely AJ, Wass J, Melmed S, Banfi G, Barkan A, Beckers A, Bidlingmaier M, Boguszewski C, Brue T, Buchfelder M, Chanson P, Chiloiro S, Colao A, Coopmans E, Esposito D, Ferone D, Frara S, Gadelha M, Geer EB, Ghigo E, Greenman Y, Gurnell M, Ho K, Ioachimescu A, Johannsson G, Jørgensen JO, Kaiser UB, Karavitaki N, Katznelson L, Lamberts S, Losa M, Luger A, Luque R, Maffei P, Marazuela M, Neggers S, Pereira A, Persani L, Petersenn S, Reincke M, Salvatori R, Samson SN, Schilbach K, Shimon I, Tsagarakis S, Zatelli MC (2024) Consensus on criteria for acromegaly diagnosis and remission. Pituitary 27(1):7–22
Article CAS PubMed Google Scholar
Mercado M, Melgar V, Salame L, Cuenca D (2017) Clinically non-functioning pituitary adenomas: pathogenic, diagnostic and therapeutic aspects. Endocrinología, Diabetes y Nutrición (English ed.) 64(7):384–395
Beck-Peccoz P, Lania A, Beckers A, Chatterjee K, Wemeau J-L (2013) 2013 European Thyroid Association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors. Eur Thyroid J 2(2):76–82
Article CAS PubMed PubMed Central Google Scholar
Fleseriu M, Langlois F, Lim DST, Varlamov EV, Melmed S (2022) Acromegaly: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol 10(11):804–826
Article CAS PubMed Google Scholar
Gadelha M, Gatto F, Wildemberg LE, Fleseriu M (2023) Cushing’s syndrome. Lancet 402(10418):2237–2252
Haidenberg-David F, Sidauy-Adissi J, Moscona-Nissan A, Jonguitud-Zumaya E, Fugarolas-Morinelli M, Martinez-Mendoza F, Taniguchi-Ponciano K, Marrero-Rodríguez D, Mercado M (2024) Overview of hyperprolactinemia: general approach and reproductive health implications. Arch Med Res 55(8):103102. https://doi.org/10.1016/j.arcmed.2024.103102
Article CAS PubMed Google Scholar
Lloyd RV, Osamura RY KG (2017) WHO classification of tumours of endocrine organs. Forth Edit. (IARC Press, ed.). Lyon
Yildirim AE, Divanlioglu D, Nacar OA, Dursun E, Sahinoglu M, Unal T, Belen AD (2013) Incidence, hormonal distribution and postoperative follow up of atypical pituitary adenomas. Turk Neurosurg 23(2):226–231
Zada G, Woodmansee WW, Ramkissoon S, Amadio J, Nose V, Laws ER (2011) Atypical pituitary adenomas: incidence, clinical characteristics, and implications. J Neurosurg 114(2):336–344
Chiloiro S, Doglietto F, Trapasso B, Iacovazzo D, Giampietro A, Di Nardo F, De Waure C, Lauriola L, Mangiola A, Anile C, Maira G, De Marinis L, Bianchi A (2015) Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis. Neuroendocrinology 101(2):143–150
Article CAS PubMed Google Scholar
Raverot G, Dantony E, Beauvy J, Vasiljevic A, Mikolasek S, Borson-Chazot F, Jouanneau E, Roy P, Trouillas J (2017) Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification. J Clin Endocrinol Metab 102(9):3368–3374
Lelotte J, Mourin A, Fomekong E, Michotte A, Raftopoulos C, Maiter D (2018) Both invasiveness and proliferation criteria predict recurrence of non-functioning pituitary macroadenomas after surgery: a retrospective analysis of a monocentric cohort of 120 patients. Eur J Endocrinol 178(3):237–246
Article CAS PubMed Google Scholar
Asioli S, Righi A, Iommi M, Baldovini C, Ambrosi F, Guaraldi F, Zoli M, Mazzatenta D, Faustini-Fustini M, Rucci P, Giannini C, Foschini MP (2019) Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre. Eur J Endocrinol 180(2):127–134
Article CAS PubMed Google Scholar
Calandrelli R, Mattogno PP, Chiloiro S, Gessi M, D’Apolito G, Tartaglione T, Giampietro A, Bianchi A, Doglietto F, Lauretti L, Gaudino S (2024) Trouillas’s grading and post-surgical tumor residue assessment in pituitary adenomas: the importance of the multidisciplinary approach. Diagnostics 14(3):274
Article PubMed PubMed Central Google Scholar
Sahakian N, Appay R, Resseguier N, Graillon T, Piazzola C, Laure C, Figarella-Branger D, Régis J, Castinetti F, Brue T, Dufour H, Cuny T (2022) Real-life clinical impact of a five-tiered classification of pituitary tumors. Eur J Endocrinol 187(6):893–904
Article CAS PubMed Google Scholar
Mondin A, Bovo G, Barbot M, Fleseriu M, Denaro L, Scaroni C, Ceccato F (2025) PANOMEN-3 grading score is reliable in predicting pituitary adenoma behavior and prognosis: a single center cohort study. Endocrine. https://doi.org/10.1007/s12020-025-04292-x
Giustina A, Uygur MM, Frara S, Barkan A, Biermasz NR, Chanson P, Freda P, Gadelha M, Haberbosch L, Kaiser UB, Lamberts S, Laws E, Nachtigall LB, Popovic V, Reincke M, van der Lely AJ, Wass JAH, Melmed S, Casanueva FF (2024) Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE). Pituitary. https://doi.org/10.1007/s11102-024-01397-w
Comments (0)